You’re invited to join Boehringer Ingelheim Pharmaceuticals, Inc. for dinner and a Non-CME educational event on Monday, May 20, 2024, at 6:30pm PT at the Marriott Marquis, Marina Ballroom F/G.
At this non-CME educational event, Dr. Cedric “Jamie” Rutland will explore the use of OFEV® (nintedanib) capsules, while emphasizing the importance of patient-centered care through the narrative of a patient mentor. The audience will gain insights into the pharmacology of OFEV, and Dr. Rutland will highlight key efficacy and safety data. Before the clinical data is presented, Sylvia R., a patient mentor, will share their personal journey of diagnosis and provide a firsthand account of their treatment with OFEV. This presentation will education the audience on the clinical data of OFEV and offer a real-world perspective on the use and impact of OFEV. This presentation is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Expert Faculty:
Cedric “Jamie” Rutland, MD
CEO and Medical Director, Rutland Medical Group
Riverside, CA
An Industry Supported Symposium at the ATS 2024 International Conference. This evening educational program is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. open to all ATS 2024 International Conference attendees.
This is a non-CME event and does not qualify for CME or CE credit. Onsite registration/admission will occur for conference registrants only at the symposium entrance, on a first-come, first-serve basis.
Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing medical education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.